DEI
Research Equity and Enrolling Non-English Speakers
This blog explains how including participants with limited English proficiency (LEP) can help improve research access and diversity.
Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor?
Register for our webinar for a discussion on why it’s important to recruit diverse patients of all backgrounds.
Aidan Gannon and Jessica Perry Examine the Patient-centric Revolution
In this episode, Aidan Gannon of Advarra and Jessica Perry of Moderna discuss patient centricity in clinical research.
Addressing Barriers to DEI in Clinical Research
A diverse, equitable, & inclusive research environment benefits everyone: trials & the communities alike. How can sites incorporate more DEI?
The Power Of Patient Advocacy In Drug Development
This blog outlines the origins and rise of patient advocacy groups, discussing the milestones in the FDA's acceptance of these groups.
Cheryl Byers and Dr. John H. Stewart Discuss Diversity, Equity and Inclusion in Cancer Research
Diversity, equity, and inclusion (DEI) in cancer research are critical to clinical research. In this episode, Advarra’s Cheryl Byers and Dr. John H. Stewart have a discussion on what is DEI, the current climate of DEI in cancer research, and considerations to improve DEI in clinical trial enrollment and retention.
Defining Decentralized Clinical Trials and Understanding Their Nuances
It’s important to understand decentralized clinical trials are not one-size fits-all and oftentimes a hybrid approach is necessary. Read our latest blog outlining what to consider when rolling out decentralized clinical trials across multiple jurisdictions where laws, technological uptake, and populations will vary.
Legislation to Advance Equality and Inclusion in Oncology Clinical Trials
The Clinical Treatment Act and Henrietta Lacks Enhancing Cancer Research Act aims to increase diversity in oncology clinical trials
Community-Based Participatory Research (CBPR): A Framework for Community Engagement
Community-based participatory research (CBPR) is utilized to reduce racial and ethnic health disparities in under-represented populations.
Q&A – Racial Diversity in Clinical Trials: Building Trust in Participant Engagement
Our experts answered some of the most popular questions from "Racial Diversity in Clinical Trials: Building Trust in Participant Engagement."
Racial Diversity in Clinical Trials: Building Trust in Participant Engagement
COVID-19 has focused the importance of diversity, equity, and inclusion considerations in clinical trial enrollment. How can the research community address the root causes for lack of diversity? What actions ...
Patient Engagement and the IRB
With increased efforts to engage and include patient and participant communities more closely in research, when does an IRB review become required?
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.